What emergency contraception is recommended for a lactating woman?

Emergency Contraception in Breastfeeding Women

Levonorgestrel emergency contraceptive pills (1.5 mg single dose) are the preferred first-line option for lactating women and can be used safely without interrupting breastfeeding. 1

Recommended Options for Lactating Women

All standard emergency contraception methods are safe during breastfeeding, with the following hierarchy based on effectiveness and lactation compatibility:

First-Line: Levonorgestrel ECPs

• Dosing: 1.5 mg as a single dose OR 0.75 mg twice, 12 hours apart
• Timing: Take as soon as possible within 5 days of unprotected intercourse (most effective within 72 hours) 1
• Breastfeeding: Continue nursing without interruption—no need to pump and dump 2, 3
• Safety profile: Minimal levonorgestrel passes into breastmilk; no adverse effects on infant health, development, or milk supply documented 2, 4, 5

Second-Line: Copper IUD

• Most effective option overall (>99% efficacy) and can be continued as ongoing contraception 1
• Timing: Insert within 5 days of unprotected intercourse (or up to 5 days after ovulation if timing can be estimated) 1
• Advantage: Provides immediate long-term contraception
• Consideration: Requires clinical visit and insertion procedure

Third-Line: Ulipristal Acetate

• Dosing: 30 mg single dose
• More effective than levonorgestrel 3-5 days after intercourse 1
• Breastfeeding consideration: While safe, some sources suggest a theoretical concern; however, evidence supports safety during lactation 3, 6
• Timing: Effective up to 5 days (120 hours) after unprotected intercourse 1

Avoid: Combined Estrogen-Progestin Regimen (Yuzpe)

• Less effective than levonorgestrel or ulipristal acetate
• Higher incidence of side effects (nausea, vomiting) 1
• Not recommended when better options are available

Key Clinical Points

Effectiveness considerations:

• Levonorgestrel and ulipristal have similar effectiveness within 3 days of intercourse 1
• Ulipristal maintains superior effectiveness days 3-5 1
• Obesity caveat: Levonorgestrel may be less effective in obese women; consider ulipristal or copper IUD in this population 1

Lactation-specific evidence:

• Prospective studies show no decrease in milk supply with levonorgestrel use 2, 4
• No adverse effects on infant growth, development, or psychomotor milestones at 6-month follow-up 4
• 75% of women resume breastfeeding within 8 hours of levonorgestrel use 2
• Maternal side effects (mainly vaginal bleeding) are actually less frequent than with regular progestin-only contraceptives 2

Practical implementation:

• Consider advance provision of levonorgestrel ECPs during postpartum contraceptive counseling 1, 5
• This approach significantly reduces unplanned pregnancy rates during breastfeeding (from 5% to 0.8%) 5
• ECPs can serve as backup when lactational amenorrhea method (LAM) prerequisites expire 5

Common Pitfalls to Avoid

1. Do not delay breastfeeding after levonorgestrel use—this is unnecessary and unsupported by evidence 2, 3
2. Do not assume all ECPs are equal—ulipristal is superior for delayed presentation (>72 hours) 1
3. Do not overlook obesity—levonorgestrel effectiveness decreases with higher BMI; offer copper IUD or ulipristal instead 1
4. Do not forget the copper IUD option—it's the most effective method and provides ongoing contraception 1